China Molecular Diagnostics Market Analysed by Renub Research in Its New Report Recently Published at MarketPublishers.com
25 Nov 2015 • by Natalie Aster
LONDON – Nowadays, in China the molecular diagnostics is a billion dollar industry. Furthermore, this industry is growing YoY rapidly. Currently, molecular diagnostics has a great potential in the total China’s diagnostics market.
China is expected to carry out more than 300 million molecular diagnostic tests between 2015 and 2019. The Chinese molecular diagnostics market is led by infectious disease testing and oncology testing; this sectors account for almost equal shares of the total market.
The molecular diagnostics market in China is following an upward trend fueled by various factors, including increasing demand for high-quality healthcare products from the middle-class population, ongoing development of the infectious diseases diagnostics and growing number of private hospitals. In the meantime, the market growth is hindered by certain challenges like lack of expertise in advanced technologies in the domestic companies and deficit of lab technicians, to name a few.
New research study “China Molecular Diagnostics Market, Test Volume & Forecast” elaborated by Renub Research provides a detailed overview of the Chinese molecular diagnostics market, describes the historical development and current scenario of this market as well as gives a holistic forecast for the market up to 2019. The research report comprises a granular analysis of the market segmentation, gives data on the market volume, value and shares. Moreover, the report highlights the market dynamics, provides vital data on the market growth drivers and challenges. Six detailed profiles of the major private clinical labs and diagnostic services companies are available here.
China Molecular Diagnostics Market, Test Volume & Forecast
Published: November, 2015
Price: US$ 1,200.00
More new research reports prepared by this publisher can be found in Renub Research catalogue.